| Application no. and date | 17742277.1 (espacenet) (Federated) (European Patent Register), 20170713 | | Patent/reg. no. and date | DK/EP 3484853, 20210421 | | Publication date | 20190522 | | Priority no. and date | GB 201612238, 20160714 | | EP pub. no. and date |
EP 3484853 20190522 | | Effective date | | | Applicant/owner | Mereo BioPharma 1 Limited, 1 Cavendish Place
London, Greater London W1G 0QF, GB | | Applicant ref. no. | P76512DK01 | | Inventor | SULEIMAN, Osama, Johnson Matthey Plc.
Fine Chemicals Division (Pharmorphix)
250 Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WE, GB,
PEREZ, Lucia Romero, Johnson Matthey Plc.
Johnson Matthey Chemical Product
Orchard Road
Royston
Hertfordshire SG8 5HE, GB,
HARLACHER, Cornelius Stephan, Zihlackerstrasse 60
4153 Reinach, CH,
JONES, Stewart, Mereo Biopharma Group plc
4th Floor
1 Cavendish Place
London
Greater London W1G 0QF, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , A61P 29/00 (2006.01) , C07D 231/38 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF EN POLYMORF FORM AF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMID | | Int. application no. | GB2017052055 | | Int. publication no. | WO2018011578 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
